proxyvotesnow.com

Home › Companies › Inspire Medical Systems, Inc. › 2025-2026

Inspire Medical Systems, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Inspire Medical Systems, Inc.’s Form 8-K, filed 2026-05-05 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 13Reported items
  • 351Asset managers
  • 3,621Fund votes
  • 2026-04-30Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Inspire Medical Systems, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Inspire Medical Systems, Inc.

These tallies are Inspire Medical Systems, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-05 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Inspire Medical Systems, Inc. — official shareholder meeting results, meeting held 2026-04-30
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Gary L. Ellis 17,268,398---- 5,883,3442,135,853 Majority: yes
Elect Director: Georgia Melenikiotou 22,693,412---- 458,3302,135,853 Majority: yes
Elect Director: Dana G. Mead, Jr. 21,950,770---- 1,200,9722,135,853 Majority: yes
Proposal 2: Ratification of the Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the year ending December 31, 2026 The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's inde 25,089,422170,68227,491 ---- Majority: yes
Proposal 3: Approval, on an Advisory (Non-Binding) Basis, of the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on an advisory (non-binding) basis, the compensation of the Company's named executive officers by votin 22,508,636595,86747,239 --2,135,853 Majority: yes
Proposal 5: Approval of an Amendment to the Company's Certificate of Incorporation to Phase Out the Classified Board Structure and Provide for the Annual Election of All Directors Beginning with the Company's 2029 Annual Meeting of Stockholders The Company's s 23,121,71011,10318,929 --2,135,853 Majority: yes
Proposal 6: Approval of an Amendment and Restatement of the Inspire Medical Systems, Inc 14,330,5368,796,68624,520 --2,135,853 Majority: yes

Source: Inspire Medical Systems, Inc., Form 8-K, filed with the SEC on 2026-05-05 — read the filing on EDGAR.

How asset managers voted at the Inspire Medical Systems, Inc. 2025-2026 meeting

Each item below shows how the 351 asset managers that disclosed a Inspire Medical Systems, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Inspire Medical Systems, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, on an advisory (non- binding) basis, of the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 22,508,636AGAINST: 595,867

Inspire Medical Systems, Inc.’s own tally for this item (“Proposal 3: Approval, on an Advisory (Non-Binding) Basis, of the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on an advisory (non-binding) basis, the compensation of the Com”): 22,508,636 for, 595,867 against, per its Form 8-K filed 2026-05-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,813,153 outstanding shares: 78% for, 2% against (80% of the company cast a for/against vote).

The 347 asset managers below cast 98% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 98%
FOR: 98.0%AGAINST: 1.8%ABSTAIN: 0.1%NOT VOTED: 0.0%
Largest asset managers voting on “Approval, on an advisory (non- binding) basis, of the compensation of the Company's named executive officers.” at Inspire Medical Systems, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,798,5652 00For
BlackRock3,296,887445 00For
DEERFIELD MANAGEMENT COMPANY, L.P.2,376,2380 00For
Wellington1,814,7900 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC977,5120 00For
State Street873,2080 00For
Artisan715,4980 00For
Aberdeen680,7840 00For
Invesco640,0730 00For
Fidelity541,2150 00For
GEODE CAPITAL MANAGEMENT, LLC498,4100 00For
BAMCO INC /NY/407,3750 00For
T. Rowe Price395,4400 00For
Vestal Point Capital, LP380,8270 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)365,2110 00For
Charles Schwab341,7070 00For
Regal Partners Ltd310,48521,844 00For
RA CAPITAL MANAGEMENT, L.P.325,6630 00For
DE Shaw272,9470 00For
WILLIAM BLAIR FUNDS248,2540 00For
UBS0225,922 00Against
Soleus Capital Management, L.P.190,9040 00For
CANADA PENSION PLAN INVESTMENT BOARD177,8000 00For
Northern Trust168,0590 00For
ADAR1 Capital Management, LLC156,5460 00For

Showing the 25 largest of 347 asset managers. See all 347 in the interactive database.

2. Approval, on an advisory (non- binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

1 YEAR 86%14%

The 175 asset managers below cast 100% of the shares they voted on this item FOR (23,682 for, 0 against).

FOR: 23,682 (0.2%)ABSTAIN: 3,368 (0.0%)1 YEAR: 9,826,301 (85.8%)ONE YEAR: 1,556,990 (13.6%)1: 14,055 (0.1%)3 YEARS: 13,214 (0.1%)NOT VOTED: 11,929 (0.1%)1.0: 6,925 (0.1%)2 YEARS: 50 (0.0%)1-YEAR: 36 (0.0%)3 YEAR: 15 (0.0%)3.0: 1 (0.0%)
Largest asset managers voting on “Approval, on an advisory (non- binding) basis, of the frequency of future advisory votes on the compensation o” at Inspire Medical Systems, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock00 001 Year
DEERFIELD MANAGEMENT COMPANY, L.P.00 001 Year
Wellington00 001 Year
Vanguard00 00One Year
Charles Schwab00 001 Year
Regal Partners Ltd00 001 Year
Soleus Capital Management, L.P.00 001 Year
Northern Trust00 001 Year
Bridgewater00 001 Year
Hartford00 001 Year
BROWN CAPITAL MANAGEMENT LLC00 001 Year
Jackson National00 001 Year
Advisors' Inner Circle Fund II00 001 Year
LOS ANGELES CAPITAL MANAGEMENT LLC00 001 Year
RIVERBRIDGE PARTNERS LLC00 001 Year
Brown Capital Management Mutual Funds00 001 Year
NEW YORK STATE COMMON RETIREMENT FUND00 001 Year
Champlain Investment Partners, LLC00 001 Year
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM00 001 Year
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM00 001 Year
Russell Investments00 001 Year
Bridge Builder Trust00 001 Year
JPMorgan00 00One Year
ENVESTNET ASSET MANAGEMENT INC00 001 Year
SEI00 001 Year

Showing the 25 largest of 175 asset managers. See all 175 in the interactive database.

3. Approval, on a advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

ONE YEAR 99.0%

The 171 asset managers below cast 100% of the shares they voted on this item FOR (48,444 for, 0 against).

FOR: 48,444 (0.3%)ONE YEAR: 14,138,541 (99.0%)THREE YEARS: 84,870 (0.6%)1-YEAR: 2,641 (0.0%)
Largest asset managers voting on “Approval, on a advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of ” at Inspire Medical Systems, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard00 00One Year
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC00 00One Year
State Street00 00One Year
Artisan00 00One Year
Aberdeen00 00One Year
Invesco00 00One Year
Fidelity00 00One Year
GEODE CAPITAL MANAGEMENT, LLC00 00One Year
BAMCO INC /NY/00 00One Year
T. Rowe Price00 00One Year
Vestal Point Capital, LP00 00One Year
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)00 00One Year
RA CAPITAL MANAGEMENT, L.P.00 00One Year
DE Shaw00 00One Year
WILLIAM BLAIR FUNDS00 00One Year
UBS00 00One Year
CANADA PENSION PLAN INVESTMENT BOARD00 00One Year
ADAR1 Capital Management, LLC00 00One Year
Nuveen00 00One Year
WASATCH ADVISORS LP00 00One Year
WASATCH FUNDS TRUST00 00One Year
PRINCIPAL GLOBAL INVESTORS00 00One Year
BRAIDWELL LP00 00One Year
TIAA00 00One Year
Rock Springs Capital Management LP00 00One Year

Showing the 25 largest of 171 asset managers. See all 171 in the interactive database.

4. APPROVAL OF AN AMENDMENT AND RESTATEMENT OF THE INSPIRE MEDICAL SYSTEMS, INC. 2018 INCENTIVE AWARD PLAN.

COMPENSATIONMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

62% Majority: yes · of votes cast

FOR 62%AGAINST 38%
FOR: 14,330,536AGAINST: 8,796,686

Inspire Medical Systems, Inc.’s own tally for this item (“Proposal 6: Approval of an Amendment and Restatement of the Inspire Medical Systems, Inc”): 14,330,536 for, 8,796,686 against, per its Form 8-K filed 2026-05-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,813,153 outstanding shares: 49.7% for, 31% against (80% of the company cast a for/against vote).

The 90 asset managers below cast 81% of the shares they voted on this item FOR (8,504,587 for, 2,023,330 against).

FOR 81%AGAINST 19%
FOR: 8,504,587 (80.7%)AGAINST: 2,023,330 (19.2%)ABSTAIN: 4,868 (0.0%)
Largest asset managers voting on “APPROVAL OF AN AMENDMENT AND RESTATEMENT OF THE INSPIRE MEDICAL SYSTEMS, INC. 2018 INCENTIVE AWARD PLAN.” at Inspire Medical Systems, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,513,40173,062 00For
BlackRock2,373,5810 00For
Fidelity450,68069,533 00For
State Street9,585453,938 00Against
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)365,2110 00For
WILLIAM BLAIR FUNDS0248,254 00Against
Aberdeen0203,308 00Against
Charles Schwab165,4530 00For
T. Rowe Price0153,388 00Against
WASATCH FUNDS TRUST135,4640 00For
TIAA0117,381 00Against
Hartford103,9220 00For
Columbia Threadneedle0100,067 00Against
Jackson National52,33846,040 00For
Advisors' Inner Circle Fund II93,5000 00For
FRANKLIN STRATEGIC SERIES78,4520 00For
First Trust071,569 00Against
Brown Capital Management Mutual Funds070,742 00Against
Lincoln Financial041,571 00Against
Invesco036,801 00Against
Dimensional035,053 00Against
BNY Mellon027,359 00Against
Bridge Builder Trust24,9400 00For
Northwestern Mutual15,5569,165 00For
Voya024,719 00Against

Showing the 25 largest of 90 asset managers. See all 90 in the interactive database.

5. RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 25,089,422AGAINST: 170,682

Inspire Medical Systems, Inc.’s own tally for this item (“Proposal 2: Ratification of the Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the year ending December 31, 2026 The Company's stockholders ratified the appointment of”): 25,089,422 for, 170,682 against, per its Form 8-K filed 2026-05-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,813,153 outstanding shares: 87% for, 0.6% against (88% of the company cast a for/against vote).

The 87 asset managers below cast 99.8% of the shares they voted on this item FOR (10,525,298 for, 11,073 against).

FOR 99.8%
FOR: 10,525,298 (99.9%)AGAINST: 11,073 (0.1%)ABSTAIN: 3,368 (0.0%)
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING” at Inspire Medical Systems, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,586,4630 00For
BlackRock2,373,5810 00For
Fidelity520,2130 00For
State Street463,49924 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)365,2110 00For
WILLIAM BLAIR FUNDS248,2540 00For
Aberdeen203,3080 00For
Charles Schwab165,4530 00For
T. Rowe Price153,3880 00For
WASATCH FUNDS TRUST135,4640 00For
TIAA117,3810 00For
Hartford103,9220 00For
Columbia Threadneedle100,0670 00For
Jackson National98,3780 00For
Advisors' Inner Circle Fund II93,5000 00For
FRANKLIN STRATEGIC SERIES78,4520 00For
First Trust71,5690 00For
Brown Capital Management Mutual Funds70,7420 00For
Lincoln Financial41,5710 00For
Invesco36,8010 00For
Dimensional35,0530 00For
BNY Mellon27,3590 00For
Bridge Builder Trust24,9400 00For
Northwestern Mutual24,7210 00For
Voya24,7190 00For

Showing the 25 largest of 87 asset managers. See all 87 in the interactive database.

6. APPROVAL OF AN ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES AT THE TIME OF THE ANNUAL MEETING TO APPROVE PROPOSAL NO. 5 AND/OR PROPOSAL NO. 6.

CORPORATE GOVERNANCE

Combines 2 wordings of this item as funds reported it.

94% fund support · no official result

FOR 94%

The 86 asset managers below cast 94% of the shares they voted on this item FOR (9,853,413 for, 649,735 against).

FOR: 9,853,413 (93.8%)AGAINST: 649,735 (6.2%)ABSTAIN: 3,368 (0.0%)
Largest asset managers voting on “APPROVAL OF AN ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT” at Inspire Medical Systems, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,586,4585 00For
BlackRock2,373,5810 00For
Fidelity501,38018,833 00For
State Street10,637452,886 00Against
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)365,2110 00For
WILLIAM BLAIR FUNDS248,2540 00For
Aberdeen203,3080 00For
Charles Schwab165,4530 00For
T. Rowe Price0153,388 00Against
WASATCH FUNDS TRUST135,4640 00For
TIAA117,3810 00For
Hartford103,9220 00For
Columbia Threadneedle100,0670 00For
Jackson National98,3780 00For
Advisors' Inner Circle Fund II93,5000 00For
FRANKLIN STRATEGIC SERIES78,4520 00For
First Trust71,5690 00For
Brown Capital Management Mutual Funds70,7420 00For
Lincoln Financial41,5710 00For
Invesco36,8010 00For
Dimensional35,0530 00For
BNY Mellon27,3590 00For
Bridge Builder Trust24,9400 00For
Northwestern Mutual24,7210 00For
Voya24,7190 00For

Showing the 25 largest of 86 asset managers. See all 86 in the interactive database.

7. APPROVAL OF AN AMENDMENT TO THE COMPANY'S SEVENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO PHASE OUT THE CLASSIFIED BOARD STRUCTURE AND PROVIDE FOR THE ANNUAL ELECTION OF ALL DIRECTORS BEGINNING WITH THE COMPANY'S 2029 ANNUAL MEETING OF STOCKHOLDERS.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 23,121,710AGAINST: 11,103

Inspire Medical Systems, Inc.’s own tally for this item (“Proposal 5: Approval of an Amendment to the Company's Certificate of Incorporation to Phase Out the Classified Board Structure and Provide for the Annual Election of All Directors Beginning with the Company's 2029 Annual”): 23,121,710 for, 11,103 against, per its Form 8-K filed 2026-05-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,813,153 outstanding shares: 80% for, 0.1% against (80% of the company cast a for/against vote).

The 86 asset managers below cast 100% of the shares they voted on this item FOR (10,519,816 for, 0 against).

FOR 100%
FOR: 10,519,816 (100.0%)
Largest asset managers voting on “APPROVAL OF AN AMENDMENT TO THE COMPANY'S SEVENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO PHASE O” at Inspire Medical Systems, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,586,4630 00For
BlackRock2,373,5810 00For
Fidelity520,2130 00For
State Street463,5230 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)365,2110 00For
WILLIAM BLAIR FUNDS248,2540 00For
Aberdeen203,3080 00For
Charles Schwab165,4530 00For
T. Rowe Price153,3880 00For
WASATCH FUNDS TRUST135,4640 00For
TIAA117,3810 00For
Hartford103,9220 00For
Columbia Threadneedle100,0670 00For
Jackson National98,3780 00For
Advisors' Inner Circle Fund II93,5000 00For
FRANKLIN STRATEGIC SERIES78,4520 00For
First Trust71,5690 00For
Brown Capital Management Mutual Funds70,7420 00For
Lincoln Financial41,5710 00For
Invesco36,8010 00For
Dimensional35,0530 00For
BNY Mellon27,3590 00For
Bridge Builder Trust24,9400 00For
Northwestern Mutual24,7210 00For
Voya24,7190 00For

Showing the 25 largest of 86 asset managers. See all 86 in the interactive database.

8. Election of Class II Directors: Dana G. Mead, Jr.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 21,950,770WITHHELD: 1,200,972

Inspire Medical Systems, Inc.’s own tally for this item (“Elect Director: Dana G. Mead, Jr.”): 21,950,770 for, 1,200,972 withheld, per its Form 8-K filed 2026-05-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,813,153 outstanding shares: 76% for, 4% withheld (80% of the company cast a for/withheld vote).

The 86 asset managers below cast 100% of the shares they voted on this item FOR (10,308,302 for, 0 against).

FOR 98%
FOR: 10,308,302 (97.9%)ABSTAIN: 217,437 (2.1%)
Largest asset managers voting on “Election of Class II Directors: Dana G. Mead, Jr.” at Inspire Medical Systems, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,586,4580 50For
BlackRock2,373,5810 00For
Fidelity520,2130 00For
State Street463,4990 240For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)365,2110 00For
WILLIAM BLAIR FUNDS248,2540 00For
Aberdeen00 203,3080Abstain
Charles Schwab165,4530 00For
T. Rowe Price153,3880 00For
WASATCH FUNDS TRUST135,4640 00For
TIAA117,3810 00For
Hartford103,9220 00For
Columbia Threadneedle100,0670 00For
Jackson National98,3780 00For
Advisors' Inner Circle Fund II93,5000 00For
FRANKLIN STRATEGIC SERIES78,4520 00For
First Trust71,5690 00For
Brown Capital Management Mutual Funds70,7420 00For
Lincoln Financial41,5710 00For
Invesco36,8010 00For
Dimensional35,0530 00For
BNY Mellon27,3590 00For
Bridge Builder Trust24,9400 00For
Northwestern Mutual24,7210 00For
Voya24,7190 00For

Showing the 25 largest of 86 asset managers. See all 86 in the interactive database.

9. Election of Class II Directors: Gary L. Ellis

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

75% Majority: yes · of votes cast

FOR 75%WITHHELD 25%
FOR: 17,268,398WITHHELD: 5,883,344

Inspire Medical Systems, Inc.’s own tally for this item (“Elect Director: Gary L. Ellis”): 17,268,398 for, 5,883,344 withheld, per its Form 8-K filed 2026-05-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,813,153 outstanding shares: 60% for, 20% withheld (80% of the company cast a for/withheld vote).

The 86 asset managers below cast 100% of the shares they voted on this item FOR (9,105,254 for, 0 against).

FOR 87%13%
FOR: 9,105,254 (86.5%)ABSTAIN: 1,420,486 (13.5%)
Largest asset managers voting on “Election of Class II Directors: Gary L. Ellis” at Inspire Medical Systems, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,516,6050 69,8580For
BlackRock2,373,5810 00For
Fidelity469,5130 50,7000For
State Street463,0460 4770For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)00 365,2110Abstain
WILLIAM BLAIR FUNDS00 248,2540Abstain
Aberdeen00 203,3080Abstain
Charles Schwab165,4530 00For
T. Rowe Price153,3880 00For
WASATCH FUNDS TRUST135,4640 00For
TIAA117,3810 00For
Hartford103,9220 00For
Columbia Threadneedle100,0670 00For
Jackson National10,1740 88,2040Abstain
Advisors' Inner Circle Fund II93,5000 00For
FRANKLIN STRATEGIC SERIES78,4520 00For
First Trust00 71,5690Abstain
Brown Capital Management Mutual Funds70,7420 00For
Lincoln Financial00 41,5710Abstain
Invesco36,8010 00For
Dimensional00 35,0530Abstain
BNY Mellon3,5110 23,8480Abstain
Bridge Builder Trust24,9400 00For
Northwestern Mutual15,5560 9,1650For
Voya00 24,7190Abstain

Showing the 25 largest of 86 asset managers. See all 86 in the interactive database.

10. Election of Class II Directors: Georgia Melenikiotou

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 22,693,412WITHHELD: 458,330

Inspire Medical Systems, Inc.’s own tally for this item (“Elect Director: Georgia Melenikiotou”): 22,693,412 for, 458,330 withheld, per its Form 8-K filed 2026-05-05 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 28,813,153 outstanding shares: 79% for, 2% withheld (80% of the company cast a for/withheld vote).

The 86 asset managers below cast 100% of the shares they voted on this item FOR (10,517,976 for, 0 against).

FOR 99.9%
FOR: 10,517,976 (99.9%)ABSTAIN: 7,763 (0.1%)
Largest asset managers voting on “Election of Class II Directors: Georgia Melenikiotou” at Inspire Medical Systems, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,586,4610 20For
BlackRock2,373,5810 00For
Fidelity520,2130 00For
State Street463,5230 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)365,2110 00For
WILLIAM BLAIR FUNDS248,2540 00For
Aberdeen203,3080 00For
Charles Schwab165,4530 00For
T. Rowe Price153,3880 00For
WASATCH FUNDS TRUST135,4640 00For
TIAA117,3810 00For
Hartford103,9220 00For
Columbia Threadneedle100,0670 00For
Jackson National98,3780 00For
Advisors' Inner Circle Fund II93,5000 00For
FRANKLIN STRATEGIC SERIES78,4520 00For
First Trust71,5690 00For
Brown Capital Management Mutual Funds70,7420 00For
Lincoln Financial41,5710 00For
Invesco36,8010 00For
Dimensional35,0530 00For
BNY Mellon27,3590 00For
Bridge Builder Trust24,9400 00For
Northwestern Mutual24,7210 00For
Voya24,7190 00For

Showing the 25 largest of 86 asset managers. See all 86 in the interactive database.

11. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 61%ONE YEAR 39%

The 6 asset managers below cast 100% of the shares they voted on this item FOR (40,448 for, 0 against).

FOR: 40,448 (60.8%)ONE YEAR: 26,025 (39.1%)1 YEAR: 16 (0.0%)
Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at Inspire Medical Systems, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
NORDEA INVESTMENT MANAGEMENT AB40,4480 00For
Empower00 00One Year
WASHINGTON CAPITAL MANAGEMENT, INC00 00One Year
APG Asset Management US Inc.00 00One Year
Arjuna Capital00 001 Year
Coyle Financial Counsel LLC00 001 Year

12. 14A Executive Compensation Vote Frequency

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 26%1 YEAR 74%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (69 for, 0 against).

FOR: 69 (25.7%)1 YEAR: 200 (74.3%)
Largest asset managers voting on “14A Executive Compensation Vote Frequency” at Inspire Medical Systems, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Baker Avenue Asset Management, LP00 001 Year
River Street Advisors LLC690 00For

13. Amend Omnibus Stock Plan

SECTION 14A SAY-ON-PAY VOTES

0% fund support · no official result

AGAINST 100%

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 24,098 against).

AGAINST: 24,098 (100.0%)
Largest asset managers voting on “Amend Omnibus Stock Plan” at Inspire Medical Systems, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Empower019,923 00Against
WASHINGTON CAPITAL MANAGEMENT, INC04,175 00Against

Largest Inspire Medical Systems, Inc. shareholders voting in 2025-2026

Ranked by the number of Inspire Medical Systems, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 28,813,153 shares outstanding at the time of that meeting.

Top Inspire Medical Systems, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 16.65%
2BlackRock 11.44%
3DEERFIELD MANAGEMENT COMPANY, L.P. 8.25%
4Wellington 6.30%
5WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 3.39%
6State Street 3.03%
7Artisan 2.48%
8Aberdeen 2.36%
9Invesco 2.22%
10Fidelity 1.88%

Reported Inspire Medical Systems, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Inspire Medical Systems, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 12.32% 13F
Vanguard Group 10.25% 13F
Wellington Management 8.80% 13F
Vanguard Portfolio Management 7.38% 13G
Soleus Capital Master Fund, L.P. 6.70% 13G
AQR Capital Management, LLC 6.44% 13G
Deerfield Mgmt, L.P. 4.50% 13G
Morgan Stanley 4.37% 13F
D.E. Shaw 4.16% 13F
State Street 3.32% 13F

Percentages above are of 28,813,153 shares outstanding, as reported by Inspire Medical Systems, Inc. on its Form 10-Q dated 2026-04-28 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Inspire Medical Systems, Inc.’s 10-Q dated 2026-04-28. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Inspire Medical Systems, Inc.'s shareholder meeting held 2026-04-30, in the 2025-2026 proxy season, 351 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,621 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory (non- binding) basis, of the compensation of the Company's named… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Inspire Medical Systems, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-05.

Inspire Medical Systems, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).